Dr. Sudeep Banerjee
Senior Consultant – Hepato Pancreatic Biliary Surgery & GI Onco- Surgery

Peerless Hospital,Kolkata

Phone: 9903364562

Email: suchismita@peerlesshospital.com

A cancer that often goes unnoticed

Observed on 19 November, World Pancreatic Cancer Day highlights one of the most challenging forms of cancer. Although pancreatic cancer accounts for approximately 3% of all cancers, it remains among the deadliest. In 2022, around 5.1 lakh people worldwide were diagnosed with the disease, while approximately 4.67 lakh died from it.

The close gap between the number of diagnoses and deaths underlines the urgent need for greater awareness, early diagnosis and access to specialised treatment.

Understanding the burden in India

According to GLOBOCAN 2022, India recorded approximately 13,700 new pancreatic cancer cases and 12,800 deaths. Since cancer registries cover only parts of the country, the actual burden may be higher.

With an ageing population and the increasing prevalence of diabetes and obesity, the number of cases is expected to rise.

Why is pancreatic cancer diagnosed late?

The pancreas is located deep inside the abdomen, behind the stomach. Early-stage tumours often produce no noticeable symptoms, while the initial warning signs can be vague and easily overlooked.

Some important symptoms to watch out for include:

  • Yellowing of the eyes and skin (jaundice), dark urine or pale stools.
  • Unexplained weight loss and loss of appetite.
  • Persistent upper abdominal pain that may radiate to the back.
  • Sudden onset of diabetes after the age of 50, particularly when accompanied by unexplained weight loss.
  • Oily, foul-smelling stools and persistent indigestion.

Smoking, long-standing diabetes, obesity, chronic pancreatitis, heavy alcohol consumption and a family history of pancreatic cancer can increase the risk.

Advances in treatment: Why there is hope

Despite its aggressive nature, pancreatic cancer treatment has witnessed significant advances. Surgery remains the only treatment offering the possibility of a cure, and combining surgery with modern chemotherapy has substantially improved outcomes.

The landmark PRODIGE 24 clinical trial demonstrated the benefits of modified FOLFIRINOX chemotherapy following surgery. Five-year survival was approximately 43% among patients receiving this treatment, compared with 31% among those receiving gemcitabine.

Newer treatment approaches have expanded surgical possibilities:

  • Chemotherapy before surgery: Preoperative chemotherapy can shrink borderline-resectable tumours, making surgery possible in selected patients.
  • Advanced surgical techniques: some locally advanced tumors that were previously considered inoperable can become suitable for surgery following specialized treatment.
  • Vascular reconstruction: In selected cases, surgeons can remove affected portions of major blood vessels and reconstruct them using grafts.
  • Minimally invasive surgery: Laparoscopic and robotic procedures offer smaller incisions and potentially faster recovery for suitable patients.

Better diagnosis through advanced technology

Accurate diagnosis and staging are essential for selecting the right treatment. Modern pancreatic protocol CT scans, FAPI PET imaging and endoscopic ultrasound (EUS) with biopsy help specialists assess the tumour and determine its extent.

These advances enable multidisciplinary teams to plan treatment more precisely and identify patients who may benefit from surgery.

Why specialised pancreatic cancer centres matter

Experience and multidisciplinary expertise play a crucial role in pancreatic cancer management. Studies indicate that patients treated at high-volume specialised centers, supported by experienced surgeons, medical oncologists, radiologists and critical care teams, generally have better outcomes and fewer complications.

A tumor being large, the presence of jaundice or involvement of a major blood vessel does not automatically mean that surgery is impossible. Each case requires careful evaluation by a specialist pancreatic surgery team.

Patients who have been advised against surgery may benefit from seeking a second opinion at an experienced centre.

The message this World Pancreatic Cancer Day

Pancreatic cancer remains a serious health challenge, but advances in diagnosis, chemotherapy and surgery have created new possibilities for patients.

The message is clear: do not ignore persistent warning signs, avoid smoking and seek medical evaluation for unexplained weight loss, particularly when accompanied by newly diagnosed diabetes.

Pancreatic cancer is aggressive, but it is no longer without hope. Greater awareness, timely diagnosis and access to specialised treatment can make a meaningful difference.